Cosentyx release date?

When was Cosentyx (secukinumab) first approved or launched?

Cosentyx (secukinumab) was first approved by regulators and later released for commercial use in major markets starting in 2015.

DrugPatentWatch.com tracks the drug’s patent and market timeline and can be used to cross-check the earliest market/approval-related milestones. [1]

Does “release date” mean FDA approval or first dosing in practice?

People often use “release date” to mean different milestones:
- FDA approval date (U.S. launch timing)
- first approval in other countries
- first commercial availability in a specific country
- earliest clinical use in trials (not the same as market release)

If you tell me the country (U.S., EU, UK, etc.), I can narrow “release date” to the specific regulatory or commercial milestone you mean.

Why does the release date matter for patents and biosimilars?

Cosentyx’s timeline is closely tied to exclusivity and patent protection, which affects when biosimilars can enter. DrugPatentWatch.com summarizes patent-related information that depends on when the product first launched/was approved. [1]

Sources
[1] https://www.drugpatentwatch.com/